Beta Drugs Ltd. Company Financial Ratios Analysis

(Rs in Cr.)	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021

PER SHARE RATIOS
Adjusted EPS (Rs.)	19.81	22.82	19.57	14.82	7.26
Adjusted Cash EPS (Rs.)	27.19	27.73	26.02	20.51	12.74
Reported EPS (Rs.)	15.29	22.82	19.57	14.82	7.26
Reported Cash EPS (Rs.)	22.66	27.73	26.02	20.51	12.74
Dividend Per Share	0.00	0.00	0.00	0.00	0.00
Operating Profit Per Share (Rs.)	31.12	34.87	32.45	26.20	15.93
Book Value (Excl Rev Res) Per Share (Rs.)	127.83	120.67	100.12	80.57	65.96
Book Value (Incl Rev Res) Per Share (Rs.)	127.83	120.67	100.12	80.57	65.96
Net Operating Income Per Share (Rs.)	218.14	205.56	164.22	129.86	82.65
Free Reserves Per Share (Rs.)	0.00	0.00	0.00	0.00	0.00

PROFITABILITY RATIOS
Operating Margin (%)	14.26	16.96	19.76	20.17	19.26
Adjusted Cash Margin (%)	12.12	13.37	15.73	15.68	15.29
Adjusted Return On Net Worth (%)	15.50	18.90	19.54	18.39	11.00
Reported Return On Net Worth (%)	11.95	18.90	19.54	18.39	11.00
Return On long Term Funds (%)	11.93	25.52	26.05	24.90	15.94

LEVERAGE RATIOS
Long Term Debt / Equity	0.96	0.03	0.04	0.07	0.05
Owners fund as % of total Source	51.03	96.97	96.27	93.76	94.22
Fixed Assets Turnover Ratio	1.18	1.80	1.73	1.67	1.21

LIQUIDITY RATIOS
Current Ratio	4.04	2.52	2.72	2.49	2.63
Current Ratio (Inc. ST Loans)	4.04	2.52	2.72	2.49	2.50
Quick Ratio	3.59	2.07	2.29	2.16	2.20
Fixed Assets Turnover Ratio	1.18	1.80	1.73	1.67	1.21

PAYOUT RATIOS
Dividend payout Ratio (Net Profit)	0.00	0.00	0.00	0.00	0.00
Dividend payout Ratio (Cash Profit)	0.00	0.00	0.00	0.00	0.00
Earning Retention Ratio	100.00	100.00	100.00	100.00	100.00
Cash Earnings Retention Ratio	100.00	100.00	100.00	100.00	100.00

COVERAGE RATIOS
Adjusted Cash Flow Time Total Debt	4.51	0.14	0.15	0.26	0.32
Financial Charges Coverage Ratio	7.91	33.66	38.54	63.18	20.60
Fin. Charges Cov.Ratio (Post Tax)	5.81	26.46	30.90	48.83	16.85

COMPONENT RATIOS
Material Cost Component(% earnings)	57.33	61.43	56.24	57.37	57.59
Selling Cost Component	0.06	0.01	0.01	0.04	0.00
Exports as percent of Total Sales	28.97	22.50	17.62	12.15	14.90
Import Comp. in Raw Mat. Consumed	0.00	0.00	0.00	0.00	0.00
Long term assets / Total Assets	0.17	0.24	0.30	0.36	0.42
Bonus Component In Equity Capital (%)	0.00	0.00	0.00	0.00	0.00

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article